Top Sell
| Security | Buy | Sell ▼ | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Atara Biotherapeutics Inc. | 2 | 3 | 0 | 0 | €0.64 | €3.00 | 370.810% |
| Bristol-Myers Squibb | 11 | 3 | 1 | 0 | €39.11 | €67.64 | 72.968% |
| Fate Therapeutics Inc. | 4 | 3 | 1 | 1 | €3.40 | €8.27 | 143.482% |
| Sage Therapeutics Inc. | 5 | 3 | 1 | 0 | €11.04 | €26.71 | 141.982% |
| Larimar Therapeutics Inc. | 2 | 3 | 0 | 0 | €7.45 | €58.50 | 685.235% |
| Agenus Inc. | 3 | 2 | 1 | 0 | €0.41 | €22.25 | 5276.897% |
| Alkermes plc | 12 | 2 | 0 | 0 | €22.20 | €34.08 | 53.517% |
| Revance Therapeutics Inc. | 0 | 2 | 0 | 2 | €2.76 | - | - |
| Gritstone Oncology Inc | 3 | 2 | 1 | 0 | €0.76 | €6.43 | 741.007% |
| QuidelOrtho Corp. | 7 | 2 | 1 | 0 | €38.20 | €73.22 | 91.672% |
| Fibrogen Inc. | 1 | 2 | 0 | 0 | €1.10 | €6.00 | 444.959% |
| Nymox Pharmaceutical Corp. | 0 | 2 | 0 | 0 | €0.23 | - | - |
| Coherus Bioscien. | 2 | 2 | 0 | 0 | €1.90 | €3.00 | 57.812% |
| BioLine RX Ltd ADR | 0 | 2 | 0 | 0 | €0.59 | - | - |
| Biofrontera AG | 0 | 2 | 0 | 0 | €0.33 | €0.000 | -100.000% |
| Medigene AG | 1 | 2 | 1 | 0 | €1.30 | €1.00 | -22.780% |
| Protalix Biotherapeutics Inc. | 1 | 2 | 0 | 2 | €1.07 | €2.00 | 86.480% |
| Anavex Life Sciences Corp | 0 | 2 | 0 | 0 | €4.09 | - | - |
| Evotec SE | 3 | 1 | 0 | 0 | €9.52 | €21.50 | 125.840% |
| Synthetic Biologics Inc. | 0 | 1 | 0 | 0 | €0.35 | - | - |
| Ironwood Pharmaceuticals | 8 | 1 | 1 | 0 | €5.95 | €18.80 | 215.918% |
| Carl Zeiss Meditec AG | 2 | 1 | 0 | 0 | €93.40 | €101.00 | 8.137% |
| Carbylan Therapeutics Inc | 1 | 1 | 0 | 0 | €10.90 | €22.00 | 101.835% |
| B.R.A.I.N. Biotechnology Research and Information Network AG | 1 | 1 | 0 | 0 | €2.76 | €30.00 | 986.957% |
| Enzo Biochem. Inc. | 0 | 1 | 0 | 0 | €0.98 | - | - |